Marker Therapeutics, Inc. (MRKR)
0.93
-0.08
(-7.92%)
USD |
NASDAQ |
Oct 13, 14:33
Marker Therapeutics Price : 0.93 for Oct. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 12, 2026 | 0.9818 | 1.03 | 0.9801 | 1.01 | 107781.0 |
| Oct 09, 2026 | 0.93 | 1.00 | 0.93 | 0.9716 | 91221.00 |
| Oct 08, 2026 | 1.04 | 1.05 | 0.95 | 0.95 | 102304.0 |
| Oct 07, 2026 | 1.03 | 1.06 | 1.03 | 1.04 | 37473.00 |
| Oct 06, 2026 | 1.07 | 1.07 | 1.004 | 1.01 | 77138.00 |
| Oct 05, 2026 | 1.08 | 1.085 | 1.045 | 1.06 | 73489.00 |
| Oct 02, 2026 | 1.06 | 1.08 | 1.02 | 1.05 | 100291.0 |
| Oct 01, 2026 | 1.08 | 1.09 | 0.981 | 1.05 | 127494.0 |
| Sep 30, 2026 | 1.12 | 1.14 | 1.07 | 1.07 | 38389.00 |
| Sep 29, 2026 | 1.14 | 1.16 | 1.075 | 1.10 | 90886.00 |
| Sep 28, 2026 | 1.12 | 1.15 | 1.07 | 1.125 | 164335.0 |
| Sep 25, 2026 | 1.22 | 1.22 | 1.15 | 1.15 | 30660.00 |
| Sep 24, 2026 | 1.260 | 1.31 | 1.15 | 1.19 | 141641.0 |
| Sep 23, 2026 | 1.24 | 1.27 | 1.23 | 1.24 | 64907.00 |
| Sep 22, 2026 | 1.18 | 1.235 | 1.18 | 1.22 | 38955.00 |
| Sep 21, 2026 | 1.18 | 1.22 | 1.18 | 1.20 | 24233.00 |
| Sep 18, 2026 | 1.19 | 1.23 | 1.17 | 1.18 | 47274.00 |
| Sep 17, 2026 | 1.13 | 1.225 | 1.13 | 1.18 | 60597.00 |
| Sep 16, 2026 | 1.17 | 1.18 | 1.13 | 1.14 | 35868.00 |
| Sep 15, 2026 | 1.17 | 1.23 | 1.15 | 1.17 | 11976.00 |
| Sep 14, 2026 | 1.16 | 1.230 | 1.16 | 1.17 | 17381.00 |
| Sep 11, 2026 | 1.20 | 1.245 | 1.10 | 1.15 | 59368.00 |
| Sep 10, 2026 | 1.21 | 1.23 | 1.18 | 1.20 | 55517.00 |
| Sep 09, 2026 | 1.29 | 1.29 | 1.21 | 1.21 | 71159.00 |
| Sep 08, 2026 | 1.19 | 1.39 | 1.19 | 1.28 | 200350.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 18.60 |
| Alnylam Pharmaceuticals, Inc. | 223.66 |
| Anika Therapeutics, Inc. | 20.49 |
| Savara, Inc. | 4.83 |
| Vericel Corp. | 40.45 |
Price Related Metrics
| PS Ratio | 7.171 |
| Price to Book Value | 1.275 |
| Earnings Yield | -51.69% |
| Market Cap | 15.51M |